Quick answers
- What is Azmiro?
- Azmiro is a brand name of Testosterone cypionate, a prescription medicine. The FDA NDC Directory lists 2 Azmiro products in 1 strength and form.
- Who makes Azmiro?
- Azurity holds the FDA application for Azmiro (NDA216318, approved June 2, 2022).
- Is there a generic or store brand of Azmiro?
- Yes. The FDA NDC Directory lists 38 other products with the same active ingredients, strength and form as a Azmiro product, 38 of them generic. Ask your pharmacist whether one is right for you.
- Has Azmiro been recalled?
- No recall linked to Azmiro products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Azmiro is
Each Azmiro product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Testosterone cypionate · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| testosterone cypionate 200 mg/mL injection, solution (intramuscular) | Azmiro | 38 products, 15 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Testosterone cypionate →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA216318 | Azurity | June 2, 2022 | 2 |
Companies that list Azmiro
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Azmiro products.
- Azurity Pharmaceuticals, Inc.2 products
Recalls
No recall linked to Azmiro products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.